Pre-treatment with potent P2Y12 receptor inhibitors is associated with reduced in-hospital mortality in a real world setting of primary percutaneous coronary intervention
Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study